Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.61 - $2.54 $916,610 - $1.45 Million
-569,323 Reduced 7.12%
7,422,835 $13.4 Million
Q2 2023

Aug 11, 2023

SELL
$1.14 - $1.95 $688,554 - $1.18 Million
-603,995 Reduced 7.03%
7,992,158 $14.9 Million
Q1 2023

May 11, 2023

BUY
$1.2 - $2.19 $876,603 - $1.6 Million
730,503 Added 9.29%
8,596,153 $11.4 Million
Q4 2022

Feb 10, 2023

BUY
$1.63 - $3.52 $8.51 Million - $18.4 Million
5,218,169 Added 197.1%
7,865,650 $13.3 Million
Q3 2022

Nov 10, 2022

BUY
$0.73 - $3.74 $1.93 Million - $9.9 Million
2,647,481 New
2,647,481 $8.26 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.